Skip to main content
Top
Published in: European Journal of Nutrition 2/2022

01-03-2022 | Original Contribution

Associations of dietary glycemic index and load during pregnancy with blood pressure, placental hemodynamic parameters and the risk of gestational hypertensive disorders

Authors: Clarissa J. Wiertsema, Rama J. Wahab, Annemarie G. M. G. J. Mulders, Romy Gaillard

Published in: European Journal of Nutrition | Issue 2/2022

Login to get access

Abstract

Purpose

The aim of this study was to examine the associations of dietary glycemic index and load with gestational blood pressure, placental hemodynamic parameters and the risk of gestational hypertensive disorders.

Methods

In a population-based cohort among 3378 pregnant Dutch women, dietary glycemic index and load were assessed from food frequency questionnaires at median 13.4 (95% range 9.9–22.9) weeks gestation. Blood pressure was measured in early-, mid- and late-pregnancy. Placental hemodynamic parameters were measured in mid- and late-pregnancy by ultrasound. Data on gestational hypertensive disorders was acquired from medical records.

Results

Mean dietary glycemic index (SD) was 58 (3) and mean dietary glycemic load (SD) was 155 (47). Dietary glycemic index was not associated with blood pressure, placental hemodynamic parameters and the risk of gestational hypertensive disorders. Higher dietary glycemic load SDS was associated with a higher diastolic blood pressure in early-pregnancy, remaining after adjustment for socio-demographic and lifestyle factors ((0.98 (95% CI 0.35–1.61) mmHg per SDS increase in glycemic load). No other associations of glycemic load with blood pressure or placental hemodynamic parameters and the risk of gestational hypertensive disorders were present. No significant associations of dietary glycemic index and load quartiles with longitudinal blood pressure patterns from early to late-pregnancy were present.

Conclusion

Within this low-risk pregnant population, we did not find consistent associations of dietary glycemic index and load with blood pressure, placental hemodynamic parameters and the risk of gestational hypertensive disorders. Further studies need to assess whether the effects on gestational hemodynamic adaptations are more pronounced among high-risk women with an impaired glucose metabolism.
Appendix
Available only for authorised users
Literature
20.
25.
28.
go back to reference Chen LW, Navarro P, Murrin CM, Mehegan J, Kelleher CC, Phillips CM, The Lifeways Cross-Generation Cohort S (2019) Maternal dietary glycemic and insulinemic indexes are not associated with birth outcomes or childhood adiposity at 5 years of age in an Irish Cohort study. J Nutr 149(6):1037–1046. https://doi.org/10.1093/jn/nxz025CrossRefPubMed Chen LW, Navarro P, Murrin CM, Mehegan J, Kelleher CC, Phillips CM, The Lifeways Cross-Generation Cohort S (2019) Maternal dietary glycemic and insulinemic indexes are not associated with birth outcomes or childhood adiposity at 5 years of age in an Irish Cohort study. J Nutr 149(6):1037–1046. https://​doi.​org/​10.​1093/​jn/​nxz025CrossRefPubMed
36.
Metadata
Title
Associations of dietary glycemic index and load during pregnancy with blood pressure, placental hemodynamic parameters and the risk of gestational hypertensive disorders
Authors
Clarissa J. Wiertsema
Rama J. Wahab
Annemarie G. M. G. J. Mulders
Romy Gaillard
Publication date
01-03-2022
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 2/2022
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-021-02670-5

Other articles of this Issue 2/2022

European Journal of Nutrition 2/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.